A landmark legal victory for Bayer has been secured in a trial over its Roundup weedkiller, with a jury finding the company’s glyphosate-based herbicide did not cause cancer in a plaintiff’s case. The ruling comes as the pharmaceutical giant continues to face broader litigation, with a key settlement agreement still pending before a judge. Legal experts suggest the outcome could influence future cases involving the widely used product, which has been at the center of ongoing debates over health risks. The decision marks a pivotal moment in Bayer’s efforts to resolve thousands of lawsuits tied to Roundup’s alleged links to non-Hodgkin lymphoma.
Bayer wins Roundup weedkiller cancer trial while awaiting settlement ruling Reuters
